v3 Template

MAIA Biotechnology

Biotechnology / Oncology Boston, Massachusetts ~400 employees

Founded

Employees (Est.)

~400

20 leaders known

Total Funding

$47.5M

Funding Rounds

Last Funding

2025-12-24

About MAIA Biotechnology

MAIA Biotechnology is focused on developing telomere targeting immunotherapies for cancer treatment, aiming to innovate in the field of oncology through novel therapeutic approaches.

Products & Services

Ateganosine (THIO) Program:A clinical-stage program targeting telomeres for cancer immunotherapy.

Second-Generation Programs:Next-generation therapies under development for cancer treatment.

Specialties

Telomere Targeting Immunotherapies Cancer Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1510000 MR: - FA: approximately $1.51 million FAN: 1510000	D: 2025-12-24 FD: 2025-12-24	2 investors
2	RT: Private Placement T: - FT: Private Placement	A: 1510000 MR: - FA: $1.51 million FAN: 1510000	D: 2025-12-16 FD: 2025-12-16	2 investors
3	RT: Private Placement T: - FT: Private Placement	A: 736600 MR: - FA: 736,600 FAN: 736600	D: 2025-10-13 FD: 2025-10-13	-
4	RT: Private Placement T: - FT: Private Placement	A: 2250000 MR: - FA: approximately $2.25 million FAN: 2250000	D: 2025-09-29 FD: 2025-09-29	2 investors
5	RT: Grant T: - FT: Grant	A: 2300000 MR: - FA: 2.3 million FAN: 2300000	D: 2025-09-24 FD: 2025-09-24	1 investors
6	RT: Private Placement T: - FT: Private Placement	A: 669500 MR: - FA: approximately $669,500 FAN: 669500	D: 2025-05-27 FD: 2025-05-27	2 investors
7	RT: Private Placement T: - FT: Private Placement	A: 1080000 MR: - FA: $1.08 million FAN: 1080000	D: 2025-05-08 FD: 2025-05-08	2 investors
8	RT: Private Placement T: - FT: Private Placement	A: 1080000 MR: - FA: approximately $1.08 million FAN: 1080000	D: 2025-05-07 FD: 2025-05-07	2 investors
9	RT: Private Placement T: - FT: Private Placement	A: 1080000 MR: - FA: $1.08 million FAN: 1080000	D: 2025-05-05 FD: 2025-05-05	2 investors
10	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 1430000 MR: - FA: approximately $1.43 Million FAN: 1430000	D: 2025-02-24 FD: 2025-02-24	2 investors
11	RT: Private Placement T: - FT: Private Placement	A: 2715000 MR: - FA: $2,715,000 FAN: 2715000	D: 2025-02-18 FD: 2025-02-18	2 investors
12	RT: Private Placement T: - FT: Private Placement	A: 3400000 MR: - FA: 3.4 million FAN: 3400000	D: 2024-12-19 FD: 2024-12-19	2 investors
13	RT: Private Placement T: - FT: Private Placement	A: 950000 MR: - FA: approximately $950,000 FAN: 950000	D: 2024-12-09 FD: 2024-12-09	2 investors
14	RT: Private Placement T: - FT: Private Placement	A: 225900 MR: - FA: $225,900 FAN: 225900	D: 2024-11-01 FD: 2024-11-01	1 investors
15	RT: Private Placement T: - FT: Private Placement	A: 2440000 MR: - FA: 2.44 million FAN: 2440000	D: 2024-10-28 FD: 2024-10-28	2 investors
16	RT: Private Placement T: - FT: Private Placement	A: 19665 MR: - FA: 19,665 shares FAN: 19665	D: 2024-04-30 FD: 2024-04-30	2 investors
17	RT: Private Placement T: - FT: Private Placement	A: 1000000 MR: - FA: approximately $1.0 million FAN: 1000000	D: 2024-04-23 FD: 2024-04-23	1 investors
18	RT: Private Placement T: - FT: Private Placement	A: 1330000 MR: - FA: 1.33 million FAN: 1330000	D: 2024-03-26 FD: 2024-03-26	-
19	RT: Private Placement T: - FT: Private Placement	A: 170940 MR: - FA: 170,940 shares FAN: 170940	D: 2024-03-26 FD: 2024-03-26	2 investors
20	RT: Private Placement T: - FT: Private Placement	A: 2900000 MR: - FA: $2.9 million FAN: 2900000	D: 2024-03-14 FD: 2024-03-14	1 investors
21	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2023-11-17 FD: 2023-11-17	-
22	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 4000000 MR: - FA: $4 million FAN: 4000000	D: 2023-11-15 FD: 2023-11-15	1 investors
23	RT: Public Offering T: - FT: Public Offering	A: 5750000 MR: - FA: approximately $5.75 million FAN: 5750000	D: 2023-04-27 FD: 2023-04-27	1 investors
24	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2023-04-24 FD: 2023-04-24	1 investors

Private Placement Latest

2025-12-24

$1.5M

2 investors (Pro only)

Private Placement 2025-12-16

$1.5M

Private Placement 2025-10-13

$737K

View 23 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Leigh-Ann Durant

Senior Legal and Business Executive

Charlotte Tsou

Head of Marketing Analytics & Insights

David M. Ashley

Director, The Preston Robert Tisch Brain Tumor Center, Head, Preuss Laboratory, and Director, Pediatrics Neuro-Oncology, Duke University

Tudor Ciuleanu

Professor of Oncology

Z. Gunnur Dikmen

MD, PhD

Jerry W. Shay

Professor and Vice Chairman of the Department of Cell Biology, University of Texas Southwestern Medical Center

View 17 more team members with Pro

Unlock Full Team Directory

Key Competitors

Competitor Alpha

Series B · $50M raised

Competitor Beta

Series C · $120M raised

Competitor Gamma

Series A · $25M raised

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website: maiabiotech.com
Industries: Biotechnology / Oncology
Company Size: ~400 employees (est.)
Locations: Boston, Massachusetts
Chicago, Illinois
San Francisco, California

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro